Lyell Immunopharma (LYEL) Other Gross PP&E Adjustments (2020 - 2025)
Lyell Immunopharma's Other Gross PP&E Adjustments history spans 6 years, with the latest figure at -$19.9 million for Q3 2025.
- For Q3 2025, Other Gross PP&E Adjustments rose 45.69% year-over-year to -$19.9 million; the TTM value through Sep 2025 reached -$19.9 million, up 45.69%, while the annual FY2024 figure was $84.1 million, 18.66% down from the prior year.
- Other Gross PP&E Adjustments for Q3 2025 was -$19.9 million at Lyell Immunopharma, up from -$21.0 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $104.7 million in Q4 2022 and bottomed at -$48.4 million in Q2 2021.
- The 5-year median for Other Gross PP&E Adjustments is -$38.2 million (2024), against an average of -$8.6 million.
- The largest annual shift saw Other Gross PP&E Adjustments soared 184.33% in 2021 before it decreased 18.66% in 2024.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at $85.2 million in 2021, then increased by 22.88% to $104.7 million in 2022, then fell by 1.24% to $103.4 million in 2023, then fell by 18.66% to $84.1 million in 2024, then plummeted by 123.68% to -$19.9 million in 2025.
- Per Business Quant, the three most recent readings for LYEL's Other Gross PP&E Adjustments are -$19.9 million (Q3 2025), -$21.0 million (Q2 2025), and -$23.6 million (Q1 2025).